劉芝華，1965年生，籍貫山東，中國醫學科學院腫瘤醫院副院長，分子腫瘤學國家重點實驗室主任。北京大學生科院本科、博士，美國華盛頓州立大學博士后，1996年底加入醫科院腫瘤醫院工作至今。主要研究工作是腫瘤發生發展的分子機理及轉化研究，利用多組學數據鑒定腫瘤驅動基因，對腫瘤進行精確分型，指導臨床治療、發現新型標志物和治療靶點，闡述關鍵基因和通路的功能表型和調控機制，在基因表達調控、蛋白翻譯后修飾等方面做了系列工作。

主要研究方向為惡性腫瘤發生發展的分子機制及個體化治療，聚焦食管癌研究，鑒定腫瘤驅動基因，對腫瘤進行精準分型，指導臨床治療；發現早期診斷的分子標志物及腫瘤治療靶點，闡述關鍵基因和通路的功能表型和調控機制。

爆草黑丝美女|韩国19禁无遮挡啪啪无码网站|91精品国产自产精品男人的天堂|sm鞭打高潮喷水抽搐调教玩弄|果冻在线|日本大尺度吃奶呻吟视频|久久久久黄片|北条麻妃av免费观看|中文字幕一区二区人妻|亚洲最大天堂无码精品区,日韩 欧美 国产精品,国产肉丝袜在线观看,最爽无遮挡行房视频,成人H视频在线观看,糖心vlog冉冉,蜜桃产品一二三产区

1. Yabing Nan#, Qingyu Luo#, Xiaowei Wu X#, Shi Liu, Pengfei Zhao, Wan Chang, Aiping Zhou, Zhihua Liu*. DLGAP1-AS2-Mediated Phosphatidic Acid Synthesis Activates YAP Signaling and Confers Chemoresistance in Squamous Cell Carcinoma. Cancer Research. 2022, 82 (16): 2887–2903. (IF=13.312)

2. Jinser Miyoshi#,Zhongxu Zhu#,Aiping Luo#,Shusuke Toden, Xuantong Zhou, Daisuke Izumi, Mitsuro Kanda, Tetsuji Takayama, Iqbal Parker, Minjie Wang, Feng Gao, Ali H Zaidi, Hideo Baba H, Yasuhiro Kodera,Yongping Cui,Xin Wang*,Zhihua Liu*,Ajay Goel*. A microRNA-based liquid biopsy signature for the early detection of esophageal squamous cell carcinoma: a retrospective, prospective and multicenter study. Molecular Cancer. 2022, 21(1):44. doi: 10.1186/s12943-022-01507-x. (IF=41.444)

3. Yuanyuan Zhang#, Hongyan Chen#, Hongnan Mo#, Xueda Hu#, Ranran Gao, Yahui Zhao, Baolin Liu, Lijuan Niu, Xiaoying Sun, Xiao Yu, Yong Wang, Qing Chang, Tongyang Gong, Xiuwen Guan, Ting Hu, Tianyi Qian, Binghe Xu,* Fei Ma,* Zemin Zhang,* and Zhihua Liu*. Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancer. Cancer Cell.2021 Dec; 39(12):1578–1593. (IF=31.743)

4. Xuantong Zhou#, Min You#, Fuhui Wang, Zhenzhen Wang, Xingfa Gao, Chao Jing, Jiaming Liu, Mengyu Guo, Jiayang Li, Aiping Luo*, Huibiao Liu*, Zhihua Liu*, and Chunying Chen*. Multifunctional Graphdiyne–Cerium Oxide Nanozymes Facilitate MicroRNA Delivery and Attenuate Tumor Hypoxia for Highly Efficient Radiotherapy of Esophageal Cancer. Advanced Materials. 2021 Jun;33(24):e2100556. (IF=30.849)

5. Furong Huang#, Hongyan Chen#, Xiaolin Zhu, Tongyang Gong, Xukun Li, William Hankey, Hongyan Wang, Zhong Chen* , Qianben Wang* and Zhihua Liu*. The oncogenomic function of androgen receptor in esophageal squamous cell carcinoma is directed by GATA3. Cell Research. 2021 Mar;31(3): 362–365. (IF=25.617)

6. Qingyu Luo#, Xiaowei Wu#, Pengfei Zhao#, Yabing Nan, Wan Chang, Xiaolin Zhu, Dan Su, Zhihua Liu*. OTUD1 Activates Caspase-Independent and Caspase-Dependent Apoptosis by Promoting AIF Nuclear Translocation and MCL1 Degradation. Advanced Science. 2021 Feb;8: 2002874. (IF=16.806）

7. Yi Li#, Bin Yang, Yanchun Ma, Xiaojun Peng, Zhiyu Wang,Bin Sheng, Zichao Wei, Yongping Cui, Zhihua Liu*. Phosphoproteomics reveals therapeutic targets of esophageal squamous cell carcinoma. Signal Transduction and Targeted Therapy. 2021 Nov;6:381. (IF=18.187)

8. Yongping Cui#, Hongyan Chen#, Ruibin Xi# , Heyang Cui#, Yahui Zhao#, Enwei Xu#, Ting Yan, Xiaomei Lu, Furong Huang, Pengzhou Kong, Yang Li, Xiaolin Zhu, Jiawei Wang, Wenjie Zhu, Jie Wang, Yanchun Ma, Yong Zhou, Shiping Guo, Ling Zhang, Yiqian Liu, Bin Wang, Yanfeng Xi, Ruifang Sun, Xiao Yu, Yuanfang Zhai, Fang Wang, Jian Yang, Bin Yang, Caixia Cheng, Jing Liu, Bin Song, Hongyi Li, Yi Wang, Yingchun Zhang, Xiaolong Cheng, Qimin Zhan*, Yanhong Li *and Zhihua Liu*. Whole Genome Sequencing of 508 Patients Identifies Key Molecular Features Associated with Poor Prognosis in Esophageal Squamous Cell Carcinoma. Cell Research. 2020 May;30(10):902-913. (IF=20.507)

9. Qingyu Luo#, Xiaowei Wu#, Wan Chang, Pengfei Zhao, Yabing Nan, Xiaolin Zhu, Jonathan P. Katz, Dan Su, Zhihua Liu*. ARID1A prevents squamous cell carcinoma initiation and chemoresistance by antagonizing pRb/E2F1/c-Myc-mediated cancer stemness. Cell Death & Differentiation. 2020 June; 27:1981-1987. (IF=10.717)

10.Xiaowei Wu#, Qingyu Luo#, Pengfei Zhao, Wan Chang, Yating Wang, Tong Shu, Fang Ding, Bin Li, Zhihua Liu*. MGMT-activated DUB3 stabilizes MCL1 and drives chemoresistance in ovarian cancer. Proc Natl Acad Sci USA. 2019, 116(8):2961-2966. (IF=9.504)